CD40 antisense oligonucleotide inhibition of trinitrobenzene sulphonic acid induced rat colitis

Gao, D.; Wagner, A. H.; Fankhaenel, S.; Stojanovic, T.; Schweyer, S.; Panzner, S.; Hecker, M.
January 2005
Gut;Jan2005, Vol. 54 Issue 1, p70
Academic Journal
Background: CD154/CD40 interactions play a pivotal role both in humoral and cellular immune responses. Their involvement in the pathogenesis of chronic inflammatory bowel disease (IBD) has been revealed by increased expression of CD40 and CD154 in the inflamed mucosa of patients and the therapeutic effects of anti-CD154 antibodies in experimental colitis. Because of adverse side effects however, the use of such antibodies in patients with IBD may be limited. Aims: An alternative approach to blocking CD154/CD40 interactions by employing a CD40 antisense oligonucleotide (ODN) was explored. Results: After sequencing of the rat CD40 gene, five antisense ODNs were designed, of which one (rAS3) effectively downregulated CD40 expression in rat vascular smooth muscle cells as well as the subsequent changes in gene expression in response to CD40 stimulation. The therapeutic potency of rAS3 was evaluated in the 2,4,6-trinitrobenzene sulphonic acid (TNBS) induced colitis model of the rat. Single intracolonic injection of a liposomal formulation of rAS3 either prior to or post colitis induction markedly suppressed the inflammatory reaction in these animals monitored both macroscopically and microscopically over one week, while application of a scrambled control ODN had no such effects. Moreover, reverse transcription-polymerase chain reaction analyses revealed reduced expression of vascular cell adhesion molecule 1, interleukin 12 p40, and monocyte chemoatractive protein 1 in the inflamed mucosa, which in turn may have contributed to the decrease in leucocyte infiltration judged by immunohistochemistry. Conclusions: These results suggest that CD40 antisense ODNs effectively interfere with CD154/CD40 interactions in vivo and, therefore, may provide a novel approach to the treatment of patients with chronic IBD.


Related Articles

  • Flexible and Frozen Sugar-Modified Nucleic Acids - Modulation of Biological Activity Through Furanose Ring Dynamics in the Antisense Strand. Mangos, Maria M.; Damha, Masad J. // Current Topics in Medicinal Chemistry;Oct2002, Vol. 2 Issue 10, p1147 

    A comparison of carbohydrate modified nucleic acids has identified key structural characteristics in antisense oligonucleotides (AON) that are necessary for sufficient clinical utility, including increased duplex stability towards RNA complements and improved hydrolytic resistance towards...

  • Targeting the Expression of Anti-Apoptotic Proteins by Antisense Oligonucleotides. Delihas, Nicholas // Current Drug Targets;Jun2001, Vol. 2 Issue 2, p167 

    Antisense oligonucleotide (ASO) biotechnology has been widely used to inhibit the expression of proteins involved in human disease. ASOs are designed to bind messenger RNA transcripts via Watson-Crick base-pairing and inhibit synthesis of targeted proteins. These proteins include protein...

  • Side-effects and phosphorothioates. Eckstein, Fritz // Nature Biotechnology;Jun2002, Vol. 20 Issue 6, p549 

    Examines the side effects of the antisense oligonucleotide phosphorothioates.

  • Antisense and / or Immunostimulatory Oligonucleotide Therapeutics. Agrawal, Sudhir; Kandimalla, Ekambar R. // Current Cancer Drug Targets;Nov2001, Vol. 1 Issue 3, p197 

    Antisense technology, which is based on a simple and rational principle of Watson-Crick complementary base pairing of a short oligonucleotide with the targeted mRNA to downregulate the disease-causing gene product, has progressed tremendously in the last two decades. Antisense oligonucleotides...

  • Antisense oligonucleotides selected by hybridisation to scanning arrays are effective reagents in vivo. Sohail, Muhammad // Nucleic Acids Research;May2001, Vol. 29 Issue 10, p2041 

    Abstract Transcripts representing mRNAs of three Xenopus cyclins, B1, B4 and B5, were hybridised to arrays of oligonucleotides scanning the first 120 nt of the coding region to assess the ability of the immobilised oligonucleotides to form heteroduplexes with their targets. Oligonucleotides...

  • Challenges and Opportunities for Local and Systemic Delivery of siRNA and Antisense Oligonucleotides. Sepp-Lorenzino, L; Ruddy, MK // Clinical Pharmacology & Therapeutics;Nov2008, Vol. 84 Issue 5, p628 

    The discovery and application of oligonucleotide technologies have already changed our fundamental understanding of biology and created a wealth of possibilities for development of new therapeutic entities. A major advantage of oligonucleotide-based technologies is the potential to develop...

  • A New Concept for the Design of Antisense Oligonucleotides Based on Nucleic Acid Thermostability. Sugimoto, N.; Yasumatsu, I. // Current Medicinal Chemistry - Anti-Cancer Agents;May2001, Vol. 1 Issue 1, p95 

    The antisense method is one of the most promising anti-cancer methods, however, the design of antisense oligonucleotides is difficult because many factors affecting their activitiy and stability must be considered. Recently, the oligonucleotide stabilities related to the antisense effects were...

  • Backbone Modification of Nucleic Acids: Synthesis, Structure and Therapeutic Applications. Micklefield, Jason // Current Medicinal Chemistry;Aug2001, Vol. 8 Issue 10, p1157 

    Nucleic acids have been extensively modified by replacing the phosphodiester group or the whole sugar-phosphodiester backbone with alternative anionic, neutral and cationic structures. Several of these modified oligonucleotides exhibit improved properties including enhanced recognition and...

  • Recent Advances in the Stereocontrolled Synthesis of Antisense Phosphorothioates. Yixin Lu // Mini Reviews in Medicinal Chemistry;Mar2006, Vol. 6 Issue 3, p319 

    Antisense technology has advanced substantially in the past few decades and now is a wellestablished therapeutic approach in medicinal chemistry, and it may prove to be a valuable tool in the treatment of a wide range of diseases. Phosphorothioate oligonucleotides are among the most important...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics